About Cochlear Limited (COH)
Cochlear Limited is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Sydney, Australia. COH has been publicly traded since 1995, giving it 31+ years of trading history.
Cochlear Limited (COH) has been publicly traded since 1995, making it a 31-year-old public company. It operates in the Medical Devices industry within the Healthcare sector. The company is headquartered in Sydney, Australia and employs approximately 5,500 people. With a market capitalization of A$11 billion, COH is a large established company.
COH trades on the Australian Securities Exchange and is classified as a large-cap-cap stock with a market capitalization of approximately A$11 billion. The company employs approximately 5,500 people worldwide.
Key Statistics
- Current Price
- A$174.42
- Market Cap
- A$11.41B
- 52-Week High
- A$319.56
- 52-Week Low
- A$169.03
- Sector
- Healthcare
- Industry
- Medical Devices
COH Investment Performance
COH has declined 33.1% year-to-date in 2026. Over the past 5 years, a A$1,000 investment in COH would have grown to A$880, representing a -12.0% total return. Since its IPO in 1995, a A$1,000 investment would now be worth A$117,020.
A$1,000 Invested in Cochlear Limited (COH)
How much would A$1,000 invested in COH be worth today?
What would A$1,000 invested in COH 1 year ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2025 would be worth A$670 as of March 2026, representing a -33.0% total return.
What would A$1,000 invested in COH 3 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2023 would be worth A$763 as of March 2026, representing a -23.7% total return.
What would A$1,000 invested in COH 5 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2021 would be worth A$880 as of March 2026, representing a -12.0% total return.
What would A$1,000 invested in COH 10 years ago be worth today?
A A$1,000 investment in Cochlear Limited (COH) in 2016 would be worth A$1,936 as of March 2026, representing a +93.6% total return.
What would A$1,000 invested in COH at IPO be worth today?
A A$1,000 investment in Cochlear Limited (COH) at IPO would be worth A$117,020 as of March 2026, representing a +11602.0% total return.
Monthly Returns Heatmap
Over the past 30+ years (363 months), Cochlear Limited (COH) has averaged a monthly return of +1.65% with a median return of +1.73%. The stock had 219 positive months (60%) and 143 negative months (39%). The best month in COH's history was August 2008 with a +26.4% return, while the worst was September 2011 at -38.7%. Historically, August tends to be the strongest month (averaging +3.8%), and September the weakest (-0.2%).
COH's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 7 consecutive months of losses. The best full year was 1999 with a cumulative return of +86.7%, and the worst was 2003 at -51.9%.
Annual Returns
Over 31 years of trading history, Cochlear Limited (COH) has delivered an average annual return of +22.26% with a median return of +25.95%. The compound annual growth rate (CAGR) is +16.61%. The stock posted gains in 21 years (68%) and losses in 10 years (32%).
COH's best year was 1999 with a +123.56% gain, while the worst was 2003 at -43.65%. The longest streak of consecutive positive years was 6, and the longest losing streak was 3 years. COH achieved double-digit gains (10%+) in 20 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -33.09% | A$260.66 | A$174.42 |
| 2025 | -8.69% | A$285.48 | A$260.66 |
| 2024 | -1.64% | A$290.23 | A$285.48 |
| 2023 | +48.33% | A$195.67 | A$290.23 |
| 2022 | -4.22% | A$204.29 | A$195.67 |
| 2021 | +15.66% | A$176.64 | A$204.29 |
| 2020 | -15.90% | A$210.03 | A$176.64 |
| 2019 | +31.71% | A$159.47 | A$210.03 |
| 2018 | +2.91% | A$154.95 | A$159.47 |
| 2017 | +42.35% | A$108.85 | A$154.95 |
| 2016 | +30.72% | A$83.27 | A$108.85 |
| 2015 | +25.76% | A$66.22 | A$83.27 |
| 2014 | +37.21% | A$48.26 | A$66.22 |
| 2013 | -22.50% | A$62.27 | A$48.26 |
| 2012 | +32.48% | A$47.01 | A$62.27 |
| 2011 | -20.57% | A$59.18 | A$47.01 |
| 2010 | +20.01% | A$49.31 | A$59.18 |
| 2009 | +28.55% | A$38.36 | A$49.31 |
| 2008 | -23.94% | A$50.44 | A$38.36 |
| 2007 | +31.72% | A$38.29 | A$50.44 |
| 2006 | +29.49% | A$29.57 | A$38.29 |
| 2005 | +85.26% | A$15.96 | A$29.57 |
| 2004 | +22.38% | A$13.04 | A$15.96 |
| 2003 | -43.65% | A$23.14 | A$13.04 |
| 2002 | -13.21% | A$26.67 | A$23.14 |
| 2001 | +25.95% | A$21.17 | A$26.67 |
| 2000 | +82.27% | A$11.62 | A$21.17 |
| 1999 | +123.56% | A$5.20 | A$11.62 |
| 1998 | +88.60% | A$2.75 | A$5.20 |
| 1997 | +45.20% | A$1.90 | A$2.75 |
| 1996 | +27.23% | A$1.49 | A$1.90 |
COH Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Cochlear Limited as an investment
Valuation
COH currently trades at a trailing P/E ratio of 33.1, which is considered high relative to the broader market. The forward P/E of 24.9 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.9. The price-to-sales ratio is 4.9.
Dividends
Cochlear Limited pays a dividend to shareholders with a current yield of 2.47%. This translates to A$4.30 per share annually. The payout ratio of 82% indicates high dividend coverage.
Risk & Volatility
COH has a beta of 0.41, indicating it is less volatile than the overall market. The stock's 52-week range is A$169.03 to A$319.56, and it currently trades near its 52-week low.
Analyst Ratings
Based on 15 analyst opinions, COH has a consensus "buy" rating. The average price target of A$247.18 suggests 41.7% upside from current levels.
Frequently Asked Questions: COH
What sector is COH in? ▼
COH operates in the Healthcare sector, specifically in the Medical Devices industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has COH performed historically? ▼
Over 31 years of trading history, COH has posted gains in 21 years (68% of the time). The best year was 1999 with a +123.6% return. Past performance does not guarantee future results.
How can I invest in COH? ▼
You can invest in COH through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold COH.
Does COH pay dividends? ▼
Cochlear Limited pays a dividend to shareholders with a current yield of 2.47%. This translates to A$4.30 per share annually. The payout ratio of 82% indicates high dividend coverage.
What does Cochlear Limited do? ▼
Cochlear Limited is a Medical Devices company operating in the Healthcare sector. The company is headquartered in Sydney, Australia.
What sector is COH in? ▼
COH operates in the Healthcare sector, specifically in the Medical Devices industry.
When did COH go public? ▼
Cochlear Limited went public in 1995, making it a 31-year-old public company as of 2026.
How much would A$1,000 invested in COH 5 years ago be worth today? ▼
A A$1,000 investment in COH five years ago would be worth approximately A$880 today, representing a -12.0% return.
How much would A$1,000 invested in COH 10 years ago be worth today? ▼
A A$1,000 investment in COH ten years ago would be worth approximately A$1,936 today, representing a 93.6% total return over the decade.
What is COH's 3-year return? ▼
Over the past 3 years, COH has returned -23.7%. A A$1,000 investment would have grown to A$763.
How much would A$1,000 invested in COH at IPO be worth today? ▼
If you invested A$1,000 in COH at its IPO in 1995, it would be worth approximately A$117,020 today, a 11,602.0% return over 31 years.
Does COH pay dividends? ▼
Yes, Cochlear Limited pays a dividend with a current yield of 2.47%, which is A$4.3 per share annually.
What is COH's market cap? ▼
Cochlear Limited has a market capitalization of A$11 billion, classifying it as a large-cap company.
What is COH's P/E ratio? ▼
COH has a trailing P/E ratio of 33.1 and a forward P/E of 24.9, which measures how much investors are paying per dollar of earnings.
Is COH a buy, hold, or sell? ▼
Based on 15 opinions, COH has a consensus "buy" rating. The average price target is A$247.18.
Last updated: 3/15/2026